806598

Teoxane S.A. — FEI 3005975625

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
November 16, 2012
Fiscal Year
2013
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Geneva (Switzerland)

Additional Details

Sponsor, Contract Research Organization

Citations

IDCFRDescription
293021 CFR 812.42Sponsor began study before IRB/FDA approval
304921 CFR 812.150(b)(5)Sponsor progress reports for significant risk study
305421 CFR 812.150(b)(7)30-day sponsor notification to FDA